4//SEC Filing
Fordyce Marshall 4
Accession 0001415889-25-001242
CIK 0001831828other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:06 PM ET
Size
18.4 KB
Accession
0001415889-25-001242
Insider Transaction Report
Form 4
Fordyce Marshall
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2025-01-08$2.90/sh+9,975$28,896→ 153,578 total - Sale
Class A Common Stock
2025-01-08$41.53/sh−9,975$414,297→ 143,603 total - Exercise/Conversion
Class A Common Stock
2025-01-08$2.90/sh+5,650$16,367→ 149,253 total - Sale
Class A Common Stock
2025-01-08$42.03/sh−5,650$237,489→ 143,603 total - Exercise/Conversion
Class A Common Stock
2025-01-08$2.90/sh+1,875$5,432→ 145,478 total - Sale
Class A Common Stock
2025-01-08$42.00/sh−1,875$78,750→ 143,603 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-01-08−1,875→ 609,051 totalExercise: $2.90Exp: 2030-12-15→ Class A Common Stock (1,875 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-01-08−15,625→ 610,926 totalExercise: $2.90Exp: 2030-12-15→ Class A Common Stock (15,625 underlying)
Holdings
- 222,030(indirect: By GRAT)
Class A Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 23, 2024.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.85, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.19, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001859453
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:06 PM ET
- Size
- 18.4 KB